+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 80Years
All Genders
ID02448992

Effects of Hippocampal-Sparing Prophylactic Cranial Irradiation on Brain Metastasis and Cognitive Function in Adults With Nodal Positive Non-Small-Cell Lung Cancer After Surgery

Led by Chang Gung Memorial Hospital · Updated on 2023-05-01

90

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying whether hippocampal-sparing prophylactic cranial irradiation PCI can reduce the risk of brain metastasis in patients with locally advanced non-small-cell lung cancer NSCLC who have undergone surgery and have pathologically confirmed nodal metastasis. The study also aims to assess how this type of brain radiation affects neurocognitive functions, which are important for memory and other mental abilities. This trial addresses concerns about potential side effects of whole brain radiotherapy WBRT on brain function while trying to prevent cancer spread to the brain. Participants are randomly assigned to one of two groups one group receives hippocampal-sparing PCI after completing four cycles of platinum-based chemotherapy, with a radiation dose of 30 Gy delivered in 15 fractions over three weeks using advanced radiation techniques to protect the hippocampus. The other group is observed without receiving PCI but undergoes the same brain imaging and cognitive testing schedules as the treatment group. All participants have a CT simulation scan for treatment planning. During the study, participants undergo regular brain imaging and a series of seven standardized neuropsychological tests to evaluate multiple cognitive areas including memory, executive function, and psychomotor speed. The primary outcome is the time until brain metastasis develops within one year. Secondary outcomes include detailed assessments of neurocognitive function over up to 18 months. The trial aims to provide clear evidence about the benefits and cognitive safety of hippocampal-sparing PCI in this patient group.

CONDITIONS

Brief Title

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

Research Team

C

Chi-Cheng Yang, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here